Open-Label Study of Oral Treprostinil in Digital Ulcers

NCT00848107 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

115

Enrollment

INDUSTRY

Sponsor class

Stopped The TDE-DU-202 extension study was discontinued after the randomized, placebo-controlled TDE-DU-201 study did not meet its primary efficacy objective.

Conditions

Systemic Sclerosis

Interventions

DRUG: treprostinil diethanolamine

Sponsor

United Therapeutics